Current through Register Vol. XLI, No. 25, June 21, 2024
Section 11-8-7 - Reporting and Discipline7.1. Any or all of the appropriate licensing boards shall have the right to cancel any collaborative pharmacy practice agreement if there is satisfactory evidence that either the physician or pharmacist signatories to the agreement are not acting in accordance with the agreement.7.2. Each appropriate board with jurisdiction of either of the signatories to the agreement shall report to the other appropriate board any acts which it believes are in violation of any agreement.7.3. Any physician or pharmacist signatory to a collaborative pharmacy agreement shall be subject to additional monitoring and education or to disciplinary proceedings by the appropriate boards if the subject physician or pharmacist violates the terms of the collaborative pharmacy practice agreement. The licensure denial, complaint and disciplinary process and procedures and appeal rights set forth in each boards' practice act and rules shall apply to their respective licensees in connection with allegations of professional misconduct in connection with pharmacist-physician collaboration.7.4. In their discretion, the boards may refer and receive information from one another concerning: 7.4.1. Mutual registrants and/or respective licensees;7.4.2. Information developed during the complaint and investigation process of one board which implicates or otherwise relates to applicants, registrants and/or licensees of another board;7.4.3. Any complaints received or discovered by one board which relate to mutual applicants, registrants and/or licensees or applicants, registrants and/or licensees of the other board.7.5. It is dishonorable, unethical or unprofessional conduct for a pharmacist or a physician to engage in collaborative pharmacy practice without first entering into a written agreement which comports with the requirements of this rule and filing a complete practice notification with the boards through the process described in section 3 of this rule.